# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-24-046860
Filing Date
2024-11-12
Accepted
2024-11-12 07:35:35
Documents
47
Period of Report
2024-11-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | syre-20241112.htm iXBRL | 8-K | 52889
2 | EX-99.1 | exhibit991-8xkdatarelease.htm | EX-99.1 | 27761
3 | EX-99.2 | exhibit992-8xkdatareleas.htm | EX-99.2 | 32983
7 |  | exhibit992-8xkdatareleas001.jpg | GRAPHIC | 77151
8 |  | exhibit992-8xkdatareleas002.jpg | GRAPHIC | 284474
9 |  | exhibit992-8xkdatareleas003.jpg | GRAPHIC | 85904
10 |  | exhibit992-8xkdatareleas004.jpg | GRAPHIC | 95564
11 |  | exhibit992-8xkdatareleas005.jpg | GRAPHIC | 89434
12 |  | exhibit992-8xkdatareleas006.jpg | GRAPHIC | 121185
13 |  | exhibit992-8xkdatareleas007.jpg | GRAPHIC | 112840
14 |  | exhibit992-8xkdatareleas008.jpg | GRAPHIC | 67277
15 |  | exhibit992-8xkdatareleas009.jpg | GRAPHIC | 128939
16 |  | exhibit992-8xkdatareleas010.jpg | GRAPHIC | 64094
17 |  | exhibit992-8xkdatareleas011.jpg | GRAPHIC | 99083
18 |  | exhibit992-8xkdatareleas012.jpg | GRAPHIC | 91802
19 |  | exhibit992-8xkdatareleas013.jpg | GRAPHIC | 92599
20 |  | exhibit992-8xkdatareleas014.jpg | GRAPHIC | 94101
21 |  | exhibit992-8xkdatareleas015.jpg | GRAPHIC | 89451
22 |  | exhibit992-8xkdatareleas016.jpg | GRAPHIC | 128898
23 |  | exhibit992-8xkdatareleas017.jpg | GRAPHIC | 103663
24 |  | exhibit992-8xkdatareleas018.jpg | GRAPHIC | 81369
25 |  | exhibit992-8xkdatareleas019.jpg | GRAPHIC | 106407
26 |  | exhibit992-8xkdatareleas020.jpg | GRAPHIC | 65019
27 |  | exhibit992-8xkdatareleas021.jpg | GRAPHIC | 111586
28 |  | exhibit992-8xkdatareleas022.jpg | GRAPHIC | 139504
29 |  | exhibit992-8xkdatareleas023.jpg | GRAPHIC | 134548
30 |  | exhibit992-8xkdatareleas024.jpg | GRAPHIC | 93666
31 |  | exhibit992-8xkdatareleas025.jpg | GRAPHIC | 62737
32 |  | exhibit992-8xkdatareleas026.jpg | GRAPHIC | 124859
33 |  | exhibit992-8xkdatareleas027.jpg | GRAPHIC | 93682
34 |  | exhibit992-8xkdatareleas028.jpg | GRAPHIC | 121675
35 |  | exhibit992-8xkdatareleas029.jpg | GRAPHIC | 89500
36 |  | exhibit992-8xkdatareleas030.jpg | GRAPHIC | 88724
37 |  | exhibit992-8xkdatareleas031.jpg | GRAPHIC | 53026
38 |  | spyrelogo.jpg | GRAPHIC | 57837
| Complete submission text file | 0001628280-24-046860.txt |  | 4750891

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | syre-20241112.xsd | EX-101.SCH | 1777
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | syre-20241112_lab.xml | EX-101.LAB | 23471
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | syre-20241112_pre.xml | EX-101.PRE | 13584
49 | EXTRACTED XBRL INSTANCE DOCUMENT | syre-20241112_htm.xml | XML | 2928

Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 241443342
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)